It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2010-2011. During the financial year, The Company’s Total Income Rs. 32989 million. Net Profit after Tax for the year Rs. 13838 million. The Company’s Revenues increased from Rs. 17,412 million in 2009-10 to Rs. 23,800 million in 2010-11. Equity shares final Rs. 3625. Book value per equity share of Rs.1/- each (Previous year per equity share of Rs. 5/- each) Rs. 65/-.
The Board of Directors is pleased to recommend an equity dividend of Rs. 3.50 per equity share of face value Rs. 1/- each (previous year Rs. 13.75 per equity share of face value Rs. 5/- each) for the year ended 31st March 2011.
More Annual Report of Sun Pharmaceutical Industries Limited:
- Annual Report 1999-2000 of Sun Pharmaceutical Industries Limited
- Annual Report 2000-2001 of Sun Pharmaceutical Industries Limited
- Annual Report 2001-2002 of Sun Pharmaceutical Industries Limited
- Annual Report 2002-2003 of Sun Pharmaceutical Industries Limited
- Annual Report 2003-2004 of Sun Pharmaceutical Industries Limited
- Annual Report 2004-2005 of Sun Pharmaceutical Industries Limited
- Annual Report 2005-2006 of Sun Pharmaceutical Industries Limited
- Annual Report 2006-2007 of Sun Pharmaceutical Industries Limited
- Annual Report 2007-2008 of Sun Pharmaceutical Industries Limited
- Annual Report 2008-2009 of Sun Pharmaceutical Industries Limited
- Annual Report 2009-2010 of Sun Pharmaceutical Industries Limited
- Annual Report 2010-2011 of Sun Pharmaceutical Industries Limited
- Annual Report 2011-2012 of Sun Pharmaceutical Industries Limited
- Annual Report 2012-2013 of Sun Pharmaceutical Industries Limited
- Annual Report 2013-2014 of Sun Pharmaceutical Industries Limited
- Annual Report 2014-2015 of Sun Pharmaceutical Industries Limited
- Annual Report 2015-2016 of Sun Pharmaceutical Industries Limited
- Annual Report 2016-2017 of Sun Pharmaceutical Industries Limited
